Citation Impact
Citing Papers
Systemic Immune-Inflammation Index Predicts Prognosis of Patients after Curative Resection for Hepatocellular Carcinoma
2014 Standout
A survey of best practices for RNA-seq data analysis
2016 Standout
Hypoxia, Hypoxia-inducible Transcription Factors, and Renal Cancer
2015 StandoutNobel
Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles
2011 Standout
Predictive Value of Clinicopathological Markers for the Metachronous Bladder Cancer and Prognosis of Upper Tract Urothelial Carcinoma
2014
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2024 Standout
Cancer treatment and survivorship statistics, 2022
2022 Standout
External validation of an online nomogram in patients undergoing radical nephroureterectomy for upper urinary tract urothelial carcinoma
2013
Early repeated ureteroscopy within 6–8 weeks after a primary endoscopic treatment in patients with upper tract urothelial cell carcinoma: preliminary findings
2015
The characteristics of bladder cancer after radiotherapy for prostate cancer
2012
EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016
2016 Standout
Nephroureterectomy and segmental ureterectomy in the treatment of invasive upper tract urothelial carcinoma: A population-based study of 2299 patients
2009
European Association of Urology Guidelines on Upper Urinary Tract Urothelial Cell Carcinoma: 2015 Update
2015 Standout
Urine markers for detection and surveillance of bladder cancer
2013
Pre-treatment neutrophil-to-lymphocyte ratio may be associated with the outcome in patients treated with everolimus for metastatic renal cell carcinoma
2013
Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2014 Standout
Outcome prediction for patients with renal cell carcinoma
2015
Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysis
2013 Standout
Immune Contexture, Immunoscore, and Malignant Cell Molecular Subgroups for Prognostic and Theranostic Classifications of Cancers
2016
Prophylactic Intravesical Chemotherapy to Prevent Bladder Tumors after Nephroureterectomy for Primary Upper Urinary Tract Urothelial Carcinomas: A Systematic Review and Meta-Analysis
2013
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
2019 Standout
Validation of the pretreatment derived neutrophil–lymphocyte ratio as a prognostic factor in a European cohort of patients with upper tract urothelial carcinoma
2014
Transforming Growth Factor-β Signaling in Immunity and Cancer
2019 Standout
Prognostic Factors in Upper Urinary Tract Urothelial Carcinomas: A Comprehensive Review of the Current Literature
2012
European Guidelines on Upper Tract Urothelial Carcinomas: 2013 Update
2013
Does interleukin-6 link explain the link between tumour necrosis, local and systemic inflammatory responses and outcome in patients with colorectal cancer?
2012
Coordinated regulation of myeloid cells by tumours
2012 Standout
Autoimmune Pancreatitis: Frequency, IgG4 Expression, and Clonality of T and B Cells
2007
Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Solid Tumors: A Systematic Review and Meta-Analysis
2014 Standout
The immune contexture in cancer prognosis and treatment
2017 Standout
PTEN Deficiency and AMPK Activation Promote Nutrient Scavenging and Anabolism in Prostate Cancer Cells
2018
Impact of Smoking on Oncologic Outcomes of Upper Tract Urothelial Carcinoma After Radical Nephroureterectomy
2012
Immunoglobulin G4–Associated Cholangitis: Clinical Profile and Response to Therapy
2008 Standout
EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2013
2013 Standout
A Systematic Review and Meta-analysis of Clinicopathologic Factors Linked to Intravesical Recurrence After Radical Nephroureterectomy to Treat Upper Tract Urothelial Carcinoma
2014
Inflammation and tumor progression: signaling pathways and targeted intervention
2021 Standout
A Comparison of a Machine Learning Model with EuroSCORE II in Predicting Mortality after Elective Cardiac Surgery: A Decision Curve Analysis
2017
Prognostic factors and predictive tools for upper tract urothelial carcinoma: a systematic review
2016
Prognostic Role of Lymphovascular Invasion in Patients with Urothelial Carcinoma of the Upper Urinary Tract: An International Validation Study
2010
Expression of nuclear FIH independently predicts overall survival of clear cell renal cell carcinoma patients
2010
Bladder Cancer Incidence and Mortality: A Global Overview and Recent Trends
2016 Standout
Increased neutrophil-lymphocyte ratio is a poor prognostic factor in patients with primary operable and inoperable pancreatic cancer
2013
Systematic Evaluation of the Prognostic Impact and Intratumour Heterogeneity of Clear Cell Renal Cell Carcinoma Biomarkers
2014
Bladder cancer
2016 Standout
Updated 2016 EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer
2016 Standout
ROTS: reproducible RNA-seq biomarker detector—prognostic markers for clear cell renal cell cancer
2015
Diagnostic biomarkers in non-muscle invasive bladder cancer
2018
Oncologic control obtained after exclusive flexible ureteroscopic management of upper urinary tract urothelial cell carcinoma
2009
Global trends in the epidemiology of bladder cancer: challenges for public health and clinical practice
2023
Conditional Survival After Radical Nephroureterectomy for Upper Tract Carcinoma
2014
A Review of Integrated Staging Systems for Renal Cell Carcinoma
2012
Low biopsy volume in ureteroscopy does not affect tumor biopsy grading in upper tract urothelial carcinoma
2012
IgG4-positive plasma cell infiltration in the diagnosis of autoimmune pancreatitis
2006
Laparoscopic versus Open Nephroureterectomy: Perioperative and Oncologic Outcomes from a Randomised Prospective Study
2009
Macroscopic sessile tumor architecture is a pathologic feature of biologically aggressive upper tract urothelial carcinoma
2010
Impact of tumour location versus multifocality in patients with upper tract urothelial carcinoma treated with nephroureterectomy and bladder cuff excision: a homogeneous series without perioperative chemotherapy
2011
The role of the oncofetal IGF2 mRNA-binding protein 3 (IGF2BP3) in cancer
2014
m6A Modification in Coding and Non-coding RNAs: Roles and Therapeutic Implications in Cancer
2020 Standout
Recent advances in the diagnosis and treatment of bladder cancer
2013
IgG4-related disease
2014 Standout
Epidemiology and Risk Factors of Urothelial Bladder Cancer
2012 Standout
EAU Guidelines on Renal Cell Carcinoma: 2014 Update
2015 Standout
A systematic review shows no performance benefit of machine learning over logistic regression for clinical prediction models
2019 Standout
The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs—Part A: Renal, Penile, and Testicular Tumours
2016 Standout
The International Society of Urological Pathology (ISUP) Grading System for Renal Cell Carcinoma and Other Prognostic Parameters
2013
Gender and Bladder Cancer: A Collaborative Review of Etiology, Biology, and Outcomes
2015
ClearCode34: A Prognostic Risk Predictor for Localized Clear Cell Renal Cell Carcinoma
2014
Neutrophils in cancer: neutral no more
2016 Standout
Cancer-related inflammation and treatment effectiveness
2014 Standout
Outcomes after adjuvant chemotherapy in the treatment of high‐risk urothelial carcinoma of the upper urinary tract (UUT‐UC)
2011
Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression
2016 Standout
Renal cell carcinoma
2017 Standout
Ureteroscopic and percutaneous management of upper tract urothelial carcinoma (UTUC): systematic review
2012
HER2 overexpression is associated with worse outcomes in patients with upper tract urothelial carcinoma (UTUC)
2016
Outcomes of radical nephroureterectomy: A series from the Upper Tract Urothelial Carcinoma Collaboration
2009 Standout
NF-κB, inflammation, immunity and cancer: coming of age
2018 Standout
Changes in Renal Function Following Nephroureterectomy May Affect the Use of Perioperative Chemotherapy
2010
Genomic Subtypes of Non-invasive Bladder Cancer with Distinct Metabolic Profile and Female Gender Bias in KDM6A Mutation Frequency
2017
Impact of Diagnostic Ureteroscopy on Intravesical Recurrence and Survival in Patients With Urothelial Carcinoma of the Upper Urinary Tract
2010
Long Noncoding RNA and Cancer: A New Paradigm
2017 Standout
Association of Tumor Necrosis With Pathological Features and Clinical Outcome in 754 Patients Undergoing Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: An International Validation Study
2010
Bladder Cancer
2020 Standout
Location of the Primary Tumor is Not an Independent Predictor of Cancer Specific Mortality in Patients With Upper Urinary Tract Urothelial Carcinoma
2009
2014
Nuclear entry and export of FIH are mediated by HIF1α and exportin1, respectively
2018 StandoutNobel
Urinary Exosomes
2009
Cancer treatment and survivorship statistics, 2016
2016 Standout
Metabolic reprogramming and cancer progression
2020 StandoutScience
Cancer treatment and survivorship statistics, 2019
2019 Standout
Current Insights into Long Non-Coding RNAs in Renal Cell Carcinoma
2016
Reassessment of Prognostic Heterogeneity of pT3 Renal Pelvic Urothelial Carcinoma: Analysis in Terms of Proposed pT3 Subclassification Systems
2014
Urothelial Carcinoma of the Bladder and the Upper Tract: Disparate Twins
2012
Inflammation and prostate cancer: the role of interleukin 6 ( IL ‐6)
2013
Association between demographic factors and prognosis in urothelial carcinoma of the upper urinary tract: a systematic review and meta-analysis
2016
Template‐based lymphadenectomy in urothelial carcinoma of the renal pelvis: A prospective study
2013
The Prognostic Value of Histological Tumor Necrosis in Solid Organ Malignant Disease: A Systematic Review
2011
Presence of Intratumoral Neutrophils Is an Independent Prognostic Factor in Localized Renal Cell Carcinoma
2009
Cancer treatment and survivorship statistics, 2014
2014 Standout
Works of Thomas Chromecki being referenced
Validation of the pre-treatment neutrophil–lymphocyte ratio as a prognostic factor in a large European cohort of renal cell carcinoma patients
2013
Patterns of invasion and histological growth as prognostic indicators in urothelial carcinoma of the upper urinary tract
2006
CD24 expression in urothelial carcinoma of the upper urinary tract correlates with tumour progression
2006
Bladder tumour development after urothelial carcinoma of the upper urinary tract is related to primary tumour location
2006
External Validation of the Mayo Clinic Stage, Size, Grade, and Necrosis (SSIGN) Score for Clear-Cell Renal Cell Carcinoma in a Single European Centre Applying Routine Pathology
2008
Predictive factors of recurrence and survival of upper tract urothelial carcinomas
2011
Presence and extent of histological tumour necrosis is an adverse prognostic factor in papillary type 1 but not in papillary type 2 renal cell carcinoma
2012
Prognostic factors for upper urinary tract urothelial carcinoma
2011
Decision curve analysis assessing the clinical benefit of NMP22 in the detection of bladder cancer: secondary analysis of a prospective trial
2011
Prognostic role of ECOG performance status in patients with urothelial carcinoma of the upper urinary tract: an international study
2011
Comparison of the 2002 and 2010 TNM classification systems regarding outcome prediction in clear cell and papillary renal cell carcinoma
2012
pT classification, grade, and vascular invasion as prognostic indicators in urothelial carcinoma of the upper urinary tract
2006
Impact of gender on bladder cancer incidence, staging, and prognosis
2011
Assessing the clinical benefit of nuclear matrix protein 22 in the surveillance of patients with nonmuscle‐invasive bladder cancer and negative cytology
2011
No overt influence of lymphadenectomy on cancer-specific survival in organ-confined versus locally advanced upper urinary tract urothelial carcinoma undergoing radical nephroureterectomy: a retrospective international, multi-institutional study
2011
Prognostic value of insulin‐like growth factor II mRNA binding protein 3 in patients treated with radical prostatectomy
2011
EGFR expression in urothelial carcinoma of the upper urinary tract is associated with disease progression and metaplastic morphology
2008
Renal cell carcinoma stage migration in a single European centre over 25 years: effects on 5- and 10-year metastasis-free survival
2012
Histologic Tumor Necrosis Is an Independent Prognostic Indicator for Clear Cell and Papillary Renal Cell Carcinoma
2012
Obesity Adversely Impacts Disease Specific Outcomes in Patients With Upper Tract Urothelial Carcinoma
2011
Tumor Necrosis as Prognostic Indicator in Transitional Cell Carcinoma of the Upper Urinary Tract
2006
Prognostic Value of the Leibovich Prognosis Score Supplemented by Vascular Invasion for Clear Cell Renal Cell Carcinoma
2012
Soluble gp130 Regulates Prostate Cancer Invasion and Progression in an Interleukin-6 Dependent and Independent Manner
2011
397: CD24 Expression in Urothelial Carcinoma of the Upper Urinary Tract Correlates with Tumor Progression
2007
THE MAYO CLINIC STAGE, SIZE, GRADE AND NECROSIS (SSIGN) SCORE FOR CLEAR CELL RENAL CELL CARCINOMA: EXTERNAL VALIDATION BY A SINGLE EUROPEAN CENTRE APPLYING ROUTINE PATHOLOGY
2008
Trends of stage, grade, histology and tumour necrosis in renal cell carcinoma in a European centre surgical series from 1984 to 2010
2012
403: Desmoplasia is an Independent Prognostic Indicator in Urothelial Carcinoma of the Upper Urinary Tract
2007
Risk Stratification of Organ Confined Bladder Cancer After Radical Cystectomy Using Cell Cycle Related Biomarkers
2011
External Validation of the Leibovich Prognosis Score for Nonmetastatic Clear Cell Renal Cell Carcinoma at a Single European Center Applying Routine Pathology
2011